STERIS plc
NYSE:STE
STERIS plc
Cash from Operating Activities
STERIS plc
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
STERIS plc
NYSE:STE
|
Cash from Operating Activities
$934.3m
|
CAGR 3-Years
10%
|
CAGR 5-Years
14%
|
CAGR 10-Years
17%
|
|
Medtronic PLC
NYSE:MDT
|
Cash from Operating Activities
$6.5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
3%
|
|
Trinity Biotech PLC
NASDAQ:TRIB
|
Cash from Operating Activities
-$11.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is STERIS plc's Cash from Operating Activities?
Cash from Operating Activities
934.3m
USD
Based on the financial report for Dec 31, 2023, STERIS plc's Cash from Operating Activities amounts to 934.3m USD.
What is STERIS plc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
17%
Over the last year, the Cash from Operating Activities growth was 31%. The average annual Cash from Operating Activities growth rates for STERIS plc have been 10% over the past three years , 14% over the past five years , and 17% over the past ten years .